MiNK Therapeutics, Inc. (INKT) Misses Q1 EPS by 64c

MiNK Therapeutics, Inc. (NASDAQ: INKT) reported Q1 EPS of ($0.70), $0.64 worse than the analyst estimate of ($0.06).

For earnings history and earnings-related data on MiNK Therapeutics, Inc. (INKT) click here.

You May Also Be Interested In

• Tesla Crash Into Texas Home Now Under Federal Safety Probe - WSJ
• Comfort Systems USA names new COO and Chief Strategy Officer
• Montana-Dakota Utilities signs power deal with Applied Digital for 430 MW AI campus